What is Solid Biosciences Inc.'s restricted cash?

Solid Biosciences Inc. (SLDB) reported restricted cash of $638K in Q1 2026.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Solid Biosciences Inc. SLDB Restricted Cash

Restricted Cash at other companies

Taysha Gene Therapies, Inc.TSHA

$449K0.0%

CRISPR TherapeuticsCRSP

$7.63M-4.7%

Cogent Biosciences, Inc.COGT

$416K—

Scholar RockSRRK

$3.81M+58.2%

Sana BiotechnologySANA

$4.2M0.0%

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$872.26M+135%

Enterprise value$595.83M+223%

P/S107.8×-9.9×

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s restricted cash?: Solid Biosciences Inc. (SLDB) reported restricted cash of $638K in Q1 2026.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.